Shanghai Fosun Pharmaceutical Development Co., Ltd.
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:China
|
| gptkbp:founded |
1994
|
| gptkbp:headquarters_location |
gptkb:Shanghai
|
| https://www.w3.org/2000/01/rdf-schema#label |
Shanghai Fosun Pharmaceutical Development Co., Ltd.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:ISIN |
CNE000000X39
|
| gptkbp:keyPerson |
gptkb:Chen_Qiyu
gptkb:Wu_Yifang |
| gptkbp:notableProduct |
gptkb:COVID-19_vaccine_(in_partnership_with_BioNTech)
Artesun (artesunate for malaria) |
| gptkbp:parentOrganization |
gptkb:Fosun_International
|
| gptkbp:products |
pharmaceuticals
medical devices healthcare services |
| gptkbp:stockExchange |
gptkb:Hong_Kong_Stock_Exchange
gptkb:Shanghai_Stock_Exchange |
| gptkbp:website |
https://www.fosunpharma.com/en/
|
| gptkbp:bfsParent |
gptkb:Fosun_Pharma
|
| gptkbp:bfsLayer |
6
|